
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services demonstrated resilience in its financial performance, reporting 2Q25 revenue of $658.2 million, which surpassed estimates and consensus despite an 11% year-over-year decline. The company achieved a gross margin of 29.8%, exceeding guidance and showcasing a sequential improvement of 120 basis points, which indicates effective cost management strategies. Additionally, AMN has consistently exceeded revenue and EBITDA estimates over the past four quarters, with average surprises of +3% for revenue and +12% for EBITDA, reflecting operational strength and market adaptability.
Bears say
AMN Healthcare Services Inc reported a significant decline in several key revenue segments, with nurse and allied solutions experiencing a 9% year-over-year decrease to $101.8 million, while the physician and leadership solutions segment fell 14% year-over-year, amounting to $381.9 million. Additionally, the overall operating margin for the nurse and allied solutions segment decreased by 30 basis points quarter-over-quarter, signaling potential inefficiencies in operations. The substantial drop in vendor management system (VMS) revenue, down 31% year-over-year, further underscores the challenges facing the company’s revenue streams and operational performance.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares